Interestingly, patients with T2DM (19, 20, 21) show a similar clinical and metabolic phenotype with peripheral neuropathy, impaired wound healing, and elevated 1-deoxySLs although these patients have no mutations in the genes encoding the SPT subunits (12, 21, 22, 23). Here, AGXT is linked to type 2 diabetes mellitus.